Cindy Chang is a Counsel at Gemini and leads Gemini’s biotech counseling services. Her practice at Gemini involves advising companies in all aspects of intellectual property law, from patent prosecution and portfolio development, freedom to operate and design-around analyses, and preparing for and managing intellectual property litigation.

Cindy has extensive experience with intellectual property issues in various industries and served as in-house IP counsel at a large pharmaceutical company. She has been trained in biology and medicine and brings a deep technical understanding to legal issues in the biopharma space.

As in-house counsel, Cindy provided legal counsel on various patent-related issues, including providing freedom to operate and design-around analyses to support product selection and pipeline management, drafting IP provisions in commercial agreements, identifying patentable subject matter, patent prosecution, and advising on Hatch-Waxman and BPCIA litigation. She also provided counsel on regulatory issues relating to ANDA and 505(b)(2) submissions.

Prior to practicing law, Cindy studied cancer biology while pursuing a dual-degree MD/PhD program, researching the mechanisms underlying Yap1-driven development of hepatocellular carcinoma. She is trained in medicine, molecular genetics, and immunology.